ArticleCancer biology & medicine2012

A Randomised Controlled Phase II Trial of the Combination of XELOX with Thalidomide for the First-line Treatment of Metastatic Colorectal Cancer.

Jing Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.